If you place implants, you already understand osseointegration. I'm certainly not going to attempt to explain it to you.
What interests me—and what became very personal after experiencing multiple implant failures—is something different.
How much of what happens during osseointegration can you actually control?
You control the treatment plan. You control implant selection and positioning, surgical technique and the conditions you create at placement. You evaluate bone, establish primary stability and make decisions about loading based on the patient and the case.
Then the patient goes home. From that point forward, you're depending on a biological response that can vary considerably from one patient to another.
THE SAME PROCEDURE DOESN'T MEAN THE SAME BIOLOGY
Two patients can receive technically excellent treatment and still bring very different biological environments to the healing process.
Their inflammatory responses aren't necessarily identical. Neither are vascularity, bone metabolism, immune response, microbial burden or systemic factors that may influence healing. Smoking, glycemic control, medications, periodontal history and other patient-specific variables can further change the picture.
None of that is news to an experienced implant dentist.
The more interesting question is how much more we're becoming capable of doing about it.
Can biological risk be characterized more precisely before treatment? Can changes in the peri-implant environment be detected earlier? Can the healing environment itself be supported in ways that meaningfully improve outcomes?
That's where the conversation gets interesting.
WE'RE GETTING BETTER AT ASKING QUESTIONS ABOUT THE HOST
Much of implant dentistry has understandably focused on the implant: surface characteristics, macrogeometry, positioning, stability, loading and prosthetic considerations.
But increasingly sophisticated attention is also being paid to the host receiving the implant.
We're seeing interest in inflammatory biomarkers and microbial assessment. Researchers continue investigating photobiomodulation and its potential influence on cellular activity and healing. There's work examining whether controlled mechanical stimulation can affect bone biology and osseointegration.
Regenerative approaches continue to evolve as well, from PRF protocols to emerging research involving extracellular vesicles and exosomes.
These aren't interchangeable concepts, and they certainly aren't equally established. Some have substantial bodies of research behind them, while others remain emerging areas with important unanswered questions.
But collectively, they point toward an interesting shift:
What if improving implant outcomes isn't only about refining what we do to the implant? What if there's more we can learn about managing and supporting the biological environment receiving it?
THAT'S THE QUESTION I WANT ANSWERED
After my own implant failures, I could have spent a lot of time asking what went wrong. Instead, I've become much more interested in what else might be possible.
What could we know sooner? What could we monitor better? Which biological variables are actually modifiable? Which emerging interventions have credible evidence behind them—and which ones don't?
Those are questions worth putting in front of people who spend their careers studying them.
That's why I'm hosting Biology in Dentistry, a free live virtual Dental Summit on Thursday, October 29. We're bringing together clinicians and researchers approaching implant biology from several different directions, and I want them to help separate what we know, what looks promising and what we still need to learn.
If implant dentistry is part of your practice, I think you'll find the conversation worthwhile.
To your unstoppable success,
President
eLaunchers.Com